Carlisle sells monitoring subsidiary:
This article was originally published in Clinica
Executive Summary
Carlisle Companies has sold its subsidiary Braemar to BioTel International for an undisclosed amount. Braemar manufactures non-invasive medical recording and monitoring equipment. BioTel has a controlling interest in several monitoring companies.